Academic literature on the topic 'Dyspepsia'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Dyspepsia.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Dyspepsia"

1

Santos, Paulo Roberto, Diego Levi Silveira Monteiro, Paulo Henrique Alexandre de Paula, Vicente Lopes Monte Neto, Maria Leilah Ponte Monte Coelho, Cecília Costa Arcanjo, Fernando Lopes Ponte Neto, et al. "Dyspepsia is Associated with Low Protein and Caloric Intake among End-Stage Renal Disease Patients." International Journal for Vitamin and Nutrition Research 85, no. 3-4 (December 2015): 112–18. http://dx.doi.org/10.1024/0300-9831/a000230.

Full text
Abstract:
Abstract. Background: Dyspepsia is highly prevalent and easily assessed in end-stage renal disease (ESRD) patients undergoing hemodialysis (HD) and is not a traditional predictor of malnutrition. We sought to establish an association between dyspeptic symptoms and nutritional status in ESRD patients undergoing maintenance HD. Methods: We studied 106 ESRD patients on HD. Dyspepsia was assessed through the Porto Alegre Dyspeptic Symptoms Questionnaire (PADYQ). Scores equal to or greater than 6 classified patients as dyspeptic. Nutritional status was evaluated using serum chemistry, total body mass, muscle mass, and dietary intake. Nutritional status was compared between dyspeptic and non-dyspeptic patients. The association of PADYQ scores and the presence of dyspepsia with nutritional variables were tested. Multivariate analysis was performed to test dyspepsia as an independent predictor for dietary intake. Results: There were 41 (38.7 %) dyspeptics. Protein intake (g/kg/day) and calorie intake (kcal/kg/day) were lower among dyspeptics compared to non-dyspeptics, 1.0 ± 0.5 vs 1.3 ± 0.5 (p = 0.01) and 23.0 ± 9.2 vs 27.4 ± 10.0 (p = 0.02), respectively. More dyspeptics than non-dyspeptics presenting protein-energy wasting based on protein and calorie intake, 41.4 vs 15.3 % (p = 0.01) and 68.2 vs 38.4 % (p = 0.02), respectively. PAQYQ score was negatively correlated with protein intake (r = - 0.20; p = 0.03) and calorie intake (r = - 0.19; p = 0.04). Dyspepsia was able to predict protein (b = - 0.26; p = 0.01) and calorie (b = - 4.42; p = 0.02) intake. Conclusions: Dyspepsia is associated with low protein and calorie intake. Screening of dyspeptic symptoms can be routinely performed aiming to improve HD patients’ nutritional status.
APA, Harvard, Vancouver, ISO, and other styles
2

Bakulina, N. V., S. V. Tikhonov, and N. B. Lishchuk. "Chronic gastritis and functional dyspepsia. Unity and struggle of two opposites." Meditsinskiy sovet = Medical Council, no. 15 (October 19, 2021): 164–74. http://dx.doi.org/10.21518/2079-701x-2021-15-164-174.

Full text
Abstract:
The review article describes the epidemiology, clinical picture, pathogenesis, approaches to the diagnosis and treatment of chronic gastritis and functional dyspepsia. Chronic gastritis is an unreasonably common diagnosis in our clinical practice, which is diagnosed in patients with disturbing dyspeptic complaints. According to the agreement documents, chronic gastritis is primarily a morphological concept. Chronic gastritis has no pathognomonic clinical signs and should be diagnosed during the histological examination of the gastric mucosa. Functional dyspepsia is a diagnosis that reflects the presence of a certain symptom complex (pain or burning sensation in the epigastrium, a feeling of fullness or early satiety) in the absence of diseases that could explain the symptoms. Secondary dyspepsia is diagnosed in patients with organic diseases of the upper gastrointestinal tract, metabolic or systemic diseases that cause dyspeptic syndrome. In the process of examining a patient with disturbing dyspeptic complaints, it is advisable for the doctor to use the diagnosis “unspecified dyspepsia” – a preliminary diagnosis before laboratory and instrumental examination aimed at identifying the cause of the dyspeptic syndrome. Dyspepsia associated with H. pylori is diagnosed in patients with H. pylori infection. The diagnosis is revised over time and is competent if complaints have been relieved within 6 months after effective H. pylori eradication.The main drugs for the treatment of patients with dyspeptic complaints are proton pump inhibitors and prokinetics. Omeprazole with domperidone sustained release (SR) in a fixed dose combination is characterized by optimal efficacy and a good safety profile in patients with both functional and secondary dyspepsia and ensures a high level of treatment adherence.
APA, Harvard, Vancouver, ISO, and other styles
3

Chan, Pak-Hei, Jo-Jo Hai, Duo Huang, Mei-Han Ho, Esther W. Chan, Bernard Man-Yung Cheung, Annie On-On Chan, et al. "Burden of upper gastrointestinal symptoms in patients prescribed dabigatran for stroke prevention." SAGE Open Medicine 4 (January 1, 2016): 205031211666241. http://dx.doi.org/10.1177/2050312116662414.

Full text
Abstract:
Background: Dabigatran, a non-vitamin K antagonist oral anticoagulant, has been shown to prevent stroke in patients with non-valvular atrial fibrillation. Nonetheless, studies show that 10%–30% of those prescribed dabigatran experience dyspepsia that may eventually lead to discontinuation of therapy and loss of clinical benefit. Aim: To evaluate the gastrointestinal tolerability of dabigatran utilizing a validated questionnaire, as well as determining subsequent non-compliance and drug discontinuation. Method: This is an observational study. All patients were assessed by a validated questionnaire, Hong Kong dyspepsia index, prior to drug prescription and again 4 weeks later. Results: In this study, 115 patients with non-valvular atrial fibrillation (mean age: 74.6 ± 11.4 years; mean CHA2DS2-VASc score was 3.39 ± 1.59) were prescribed dabigatran. At baseline, the mean Hong Kong dyspepsia index was 12.9 ± 1.6 and nine patients had significant dyspepsia (Hong Kong dyspepsia index ⩾ 16). After 4 weeks, the mean Hong Kong dyspepsia index was similar at 12.6 ± 1.9 ( p = 0.23). There was no change in Hong Kong dyspepsia index after initiation of dabigatran in 59 (51.3%) patients, and improvement in 37 (32.2%). Only 19 (16.5%) patients had worsening of Hong Kong dyspepsia index, and among these 19 patients, only 1 patient (0.9%) discontinued dabigatran due to significant dyspepsia. Conclusion: Worsening of dyspepsia with dabigatran 110 mg twice daily was uncommon with correct drug administration and clear instructions provided. Systematic assessment of dyspeptic symptoms using a validated questionnaire (i.e. Hong Kong dyspepsia index) before and after treatment initiation allows a more objective comparison of dyspeptic symptoms.
APA, Harvard, Vancouver, ISO, and other styles
4

Febriani, Tien Budi, Titis Widowati, and Mohammad Juffrie. "Reducing dyspeptic symptoms in children: proton pump inhibitor vs. H2 receptor antagonist." Paediatrica Indonesiana 54, no. 4 (August 31, 2014): 198. http://dx.doi.org/10.14238/pi54.4.2014.198-201.

Full text
Abstract:
Background Dyspepsia is known as a leading cause of uppergastrointestinal tract morbidity. If left untreated, dyspepsia maybecome chronic. Dyspeptic symptoms manifest as epigastricpain, heartburn, nausea, hematemesis, or melena. Experimentalstudies have shown that omeprazole is more effective at reducingheartburn than ranitidine in adults. However, there have beenfew studies comparing the effects of proton pump inhibitorsto Hz receptor antagonists for reducing dyspeptic symptoms inchildren.Objective To compare the effect of omeprazole with ranitidinefor reducing dyspeptic symptoms .Methods We performed a double-blind randomized controlledtrial (RCT) at Sardjito Hospital and three community h ealthcenters in the Sleman District from June to November 2012.We recruited children aged 3-18 years with dyspepsia. Subjectswere allocated into two groups using block randomization:the proton pump inhibitor (omeprazole) and the Hz receptorantagonist (ranitidine) groups. According to the groups, eitheromeprazole (0.4-0 .8 mg/kg/dose) or ranitidine (2-4 mg/kg/dose) ,respectively, were taken twice daily for 5 days. Dyspepsia wasclinically diagnosed using the new Rome III criteria. Both groupswere monitored for 5 days to assess for a reduction of dyspepticsymptoms.Results Significantly more subjects in the omeprazole grouprecovered from dyspeptic symptoms than in the ranitidine group(RR= 4.87; 95%CI 1.5 to 15.3; P=0.005).Conclusion Omeprazole was 4.87 (95% CI 1.5 to 15.3) timesbetter than ranitidine in reducing dyspeptic symptoms on childrenaged 3-18 years with dyspepsia.
APA, Harvard, Vancouver, ISO, and other styles
5

Kotecha, Ravi, and Vishwa Kotecha. "Cholelithiasis and laparoscopic cholecystectomy: identifying the appropriate time for operative intervention." International Surgery Journal 8, no. 9 (August 27, 2021): 2600. http://dx.doi.org/10.18203/2349-2902.isj20213269.

Full text
Abstract:
Background: Cholelithiasis is the most common among hepatobiliary disease and often requires surgical intervention. Laparoscopic cholecystectomy is the gold standard nowadays. This research paper was done to know appropriate time for laparoscopic cholecystectomy and how much improvement will we get after laparoscopic cholecystectomy.Methods: In our prospective observational study, 118 patients of cholelithiasis, 59 with dyspepsia in one group and 59 without dyspepsia in another group were taken. Both groups patients were analysed with Bucklay validated dyspeptic score before and after laparoscopic cholecystectomy till 6 months postoperatively for score improvement.Results: In our study, we confirmed that there was improvement in Buckley validated dyspeptic score in both group of patients with dyspepsia and without dyspepsia 6 month after laparoscopic cholecystectomy but not complete improvement. Improvement in Buckley validated dyspeptic score 6 months after laparoscopic cholecystectomy was more in patients with less duration of symptoms and less frequency of episode preoperatively and in non-dyspeptic patients.Conclusions: We could conclude that even earlier surgery after onset of symptoms didn’t result in complete resolution of symptoms in both groups particularly in group B (patients with dyspepsia). We can say that weather it is dyspeptic or non-dyspeptic gallstone disease, it has benefit from laparoscopic cholecystectomy but we can also say that improvement achieved is not complete as after laparoscopic cholecystectomy there were still number of patients who had Buckley validated score more than 6 in both groups after 6 months of surgery.
APA, Harvard, Vancouver, ISO, and other styles
6

MAHESAR, M., SA BHUTTO, WS BHATTI, GR BHURGRI, U. FATIMA, M. CHANDIO, S. MANGI, et al. "ASSESSMENT OF DIETARY AND LIFESTYLE FACTORS ASSOCIATED WITH DYSPEPSIA: A QUESTIONNAIRE-BASED STUDY." Biological and Clinical Sciences Research Journal 2024, no. 1 (January 19, 2024): 668. http://dx.doi.org/10.54112/bcsrj.v2024i1.668.

Full text
Abstract:
The main aim of this study was to better understand the connections between diet patterns and lifestyle choices and the development of dyspepsia providing useful insights into the impact of various dietary and lifestyle components on dyspeptic symptoms, contributing to the creation of focused interventions and recommendations for maintaining digestive health. Among the Pakistani general population, a cross-sectional study was carried out in November 2022. Demographic data, dietary lifestyle factors and frequency of dyspepsia were evaluated. An English-based questionnaire was distributed through Google form. A question related to assessing the dyspepsia frequency in participants and to examining lifestyle factors related to diet (various food consumption consisting of salty food, fast food or any beverages), alcohol consumption, smoking, use of (NSAIDS) medications and utilization of any other home remedies. The sample size of the participants was 351. An SPSS version 25 was used for data analysis. It was observed that 19% of participants were suffering from dyspepsia. Fast food, smoking, painkillers, salty food, and stress were associated with dyspepsia whereas H. pylori, consumption of alcohol and other factors are less likely responsible for dyspepsia. Dietary factors like beverages, tea/coffee, fruits/vegetables and physical activity indicate no significant relation with dyspepsia. It was observed through this study that 14% and 18 % of people were utilizing herbal medicines and home remedies for dyspepsia respectively. However, depression and inadequate sleep had a significant impact on dyspepsia. After a thorough examination of participant data, we were able to identify several significant correlations that offer important information about the possible causes of dyspeptic symptoms.
APA, Harvard, Vancouver, ISO, and other styles
7

Yeom, Jung Sook, Myung Bum Choi, Ji-Hyun Seo, Ji Sook Park, Jae-Young Lim, Chan-Hoo Park, Hyang-Ok Woo, et al. "Relationship between headache and mucosal mast cells in pediatric Helicobacter pylori-negative functional dyspepsia." Cephalalgia 33, no. 5 (January 4, 2013): 323–29. http://dx.doi.org/10.1177/0333102412472070.

Full text
Abstract:
Background Although many patients with functional dyspepsia experience headache concurrently with dyspeptic symptoms, studies suggesting mechanisms underlying this phenomenon are limited. Herein, we explore the relationship between gastrointestinal inflammatory cells and presence of headache associated with dyspeptic symptoms in children with Helicobacter pylori-negative functional dyspepsia. Methods Fifty-six patients with H. pylori-negative functional dyspepsia underwent upper endoscopy with biopsy to investigate recurrent epigastric pain or discomfort. Patients were divided into two groups according to self-reported presence of headache associated with dyspeptic symptoms. Inflammatory cells including mast cells, and enteroendocrine cells in the gastroduodenal mucosa were evaluated. Associations between headache presence and cellular changes in the gastroduodenal mucosa were examined. Results Headache was not associated with the grade of lymphocytes, neutrophil infiltration, or enteroendocrine cell density in the gastroduedenal mucosa. However, headache was significantly associated with high mast cell density in the body (27.81 ± 8.71 vs. 20.30 ± 8.16, p < 0.01) and duodenum (23.16 ± 10.40 vs. 14.84 ± 5.88, p < 0.01). Conclusions Presence of headache associated with dyspeptic symptoms is strongly related to mucosal mast cell density in pediatric patients with H. pylori-negative functional dyspepsia. Thus, our results may help clinicians understand and treat headache during dyspeptic symptoms in such pediatric patients.
APA, Harvard, Vancouver, ISO, and other styles
8

Nessa, Azizun, Muhammad Rabiul Hossain, Md Habibur Rahman, SM Mizanur Rahman, Abdullah Al Mamun, and Javed Mahfuj Khan. "Evaluation of 105 Cases of Dyspepsia by Upper Gastrointestinal Endoscopy and Ultrasonography of Hepatobiliary System in a Rural Setting." Journal of Armed Forces Medical College, Bangladesh 11, no. 2 (January 16, 2019): 25–29. http://dx.doi.org/10.3329/jafmc.v11i2.39819.

Full text
Abstract:
Introduction: Dyspepsia affects up to 40% of the general population and significantly reduces the quality of life. Dyspeptic symptoms may be associated with endoscopically negative conditions, such as functional dyspepsia, or with organic lesions like peptic ulcer and oesophagitis which are easily detected by endoscopy. On the other hand, such lesions may also be asymptomatic and there is not always a clear cause and effect relationship between endoscopic findings and symptoms. Objective: To determine the prevalence of significant endoscopic lesion and or ultrasonographic findings and their association with dyspeptic symptoms in Bangladeshi rural population. Materials and Methods: This prospective cross sectional study was carried out in Nov 2015 to Dec 2015 in a field mobile hospital of Bangladesh Army, established in Daudkandi, Comilla where total 1094 uninvestigated dyspeptic patients were invited to participate in this cross sectional study and 105 typical dyspeptic patients were finally recruited as per Rome III criteria. Participants underwent clinical assessment through a preformed structured questionnaire and non video upper gastrointestinal endoscopy (UGIE) and ultrasonogram (USG) of hepatobiliary system (HBS). Results: The mean age of 105 participants (male-29; female-76) studied was 36.51±7.26 years with female preponderance (72.38%). Predominant symptoms were epigastric pain (69.52%), flatulence (34.28%), heart burn (28.57%) and diffuse abdominal pain (22.85%). Regarding treatment 48(45.71%) patients took proton pump inhibitors (PPI), 24 patients (22.85%) took H2 receptor blocker and 13 patients (12.38%) were on antacids irregularly. Seventeen patients (16.15%) had no history of medications for dyspepsia. Most of the patients (76.19%) had symptoms of less than 5 years. Organic dyspepsia was found in 68(64.76%) and functional dyspepsia in 37(35.23%) participants. Percentage of functional dyspepsia in male was 24.13% and in female it was 39.47% and the difference was statistically significant (p<0.05). In the organic dyspepsia group, upper GI endoscopy revealed 07(6.66%) duodenal ulcer, 02(1.9%) gastric ulcer, 04(3.8%) prepyloric ulcer and other inflammatory lesions like prepyloric gastritis in 46(43.80%) patients, antral gastritis in 06(5.7%) patients, duodenitis in 08(7.61%) patients and erosive oesophagitis in 03 patients(2.86%). Further USG revealed cholelithiasis in 02(1.90%) and gall bladder (GB) polyp in 01(0.95%) participants which could be the reason for their dyspeptic symptoms. Thirty Seven (35.23%) participants had normal UGIE (and also normal USG of HBS) but they had significant dyspeptic symptoms. Conclusion: Most of the patients (64.76%) in this study had significant upper GI endoscopic findings and labeled as organic dyspepsia and combined use of upper GI endoscopy and USG of HBS provided better yield for aetiological diagnosis of dyspepsia if there is any. Journal of Armed Forces Medical College Bangladesh Vol.11(2) 2015: 25-29
APA, Harvard, Vancouver, ISO, and other styles
9

Yasuda, Kohei, Daisuke Chinda, Tadashi Shimoyama, Tetsu Arai, Kazuki Akitaya, Sae Fujiwara, Hiroki Nomiya, et al. "Factors Predicting Effectiveness of Eradication Therapy for Helicobacter pylori-Associated Dyspepsia Symptoms." Life 14, no. 8 (July 25, 2024): 935. http://dx.doi.org/10.3390/life14080935.

Full text
Abstract:
Functional dyspepsia is distinguishable from Helicobacter pylori-associated dyspepsia. However, distinguishing H. pylori-associated dyspepsia from functional dyspepsia before H. pylori eradication is difficult. Therefore, in the present study, we aimed to investigate whether serum pepsinogen levels before H. pylori eradication are associated with the amelioration of dyspepsia after successful H. pylori eradication. Additionally, we examined the usefulness of serum pepsinogen levels and other factors in predicting dyspepsia outcomes. H. pylori eradication was effective in 14 patients (Responders) and ineffective in 19 patients (Non-responders). The pepsinogen I/II ratio in Responders (3.4 ± 1.2) and Non-responders (2.3 ± 1.0) differed significantly (p = 0.006). The optimal cut-off pepsinogen I/II value was 2.3. Multivariate logistic regression analysis showed that the adjusted odds ratio for Non-responders was 26.1 (95% confidence interval: 2.0–338.0, p = 0.012) for a pepsinogen I/II ratio ≤ 2.3 and 8.10 (95% confidence interval: 1.1–57.6, p = 0.037) for smoking habits. The pepsinogen I/II ratio and smoking habits were associated with the effects of H. pylori eradication on dyspeptic symptoms. Thus, the pepsinogen I/II ratio cut-off value can be used to identify patients likely to respond to H. pylori eradication after the resolution of dyspeptic symptoms.
APA, Harvard, Vancouver, ISO, and other styles
10

Zhestkova, T. V. "Evaluation of the dynamics of symptoms of dyspepsia after eradication therapy in patients with Helicobacter pylori-associated gastritis." Experimental and Clinical Gastroenterology, no. 10 (January 18, 2023): 14–18. http://dx.doi.org/10.31146/1682-8658-ecg-206-10-14-18.

Full text
Abstract:
The treatment of functional dyspepsia remains a complex and incompletely resolved issue of gastroenterology. Subjective sensations of the patient, described as a feeling of fullness in the epigastrium after eating, early satiety, pain in the epigastrium, may be a manifestation of dyspepsia associated with Helicobacter pylori (H. pylori) infection. Aim was evaluation of the effectiveness of standard triple eradication therapy enhanced with bismuth tripotassium dicitrate for the relief of symptoms of dyspepsia in patients with H. pylori-associated chronic gastritis. Materials and Methods. The study involved 38 patients with H. pylori-associated chronic gastritis with symptoms of dyspepsia. The Questionnaire “7 × 7” was used to describe the dynamics of symptoms of dyspepsia. Results. At the initial examination, dyspeptic disorders in most patients corresponded the criteria for mild and moderate severity, respectively - 44.7% and 28.9% of patients. The severity of pain in the stomach area on average corresponded to a moderate pain syndrome, and the burning sensation was of low intensity. A feeling of fullness in the stomach after eating and/or early satiety was experienced by 76.3% of patients, pain disorders were observed in 92.1% of individuals. Two months after successful eradication treatment, complete relief of dyspepsia symptoms was noted in 57.9% of patients, and significant relief of symptoms of the combined form of dyspepsia in 23.7% of individuals. Conclusions: Successful standard triple eradication therapy enhanced with bismuth tripotassium dicitrate is effective for the treatment of dyspeptic symptoms in patients with H. pylori-associated chronic gastritis.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Dyspepsia"

1

Jonsson, Bo H. "Psychophysiological study of functional dyspepsia /." Stockholm, 1999. http://diss.kib.ki.se/1999/91-628-3650-1/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Jones, John I. W. "Characterisation of acid-sensitive dyspepsia." Thesis, Nottingham Trent University, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.272811.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Koskenpato, Jari. "Helicobacter pylori and functional dyspepsia." Helsinki : University of Helsinki, 2001. http://ethesis.helsinki.fi/julkaisut/laa/kliin/vk/koskenpato/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Almeida, Rodrigues Isabel Maria Fragoso Carrelhas de. "Stress, personality factors and functional dyspepsia." Thesis, London South Bank University, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.414919.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bolling-Sternevald, Elisabeth. "Functional Dyspepsia : Symptoms and Response to Omeprazole in the Short Term." Doctoral thesis, Linköping : Univ, 2003. http://www.ep.liu.se/diss/med/07/92/index.html.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Jones, Roger Hugh. "Self care and primary care of dyspepsia." Thesis, University of Southampton, 1990. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.241615.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Watson, R. G. P. "A study of the pathogenesis of flatulent dyspepsia." Thesis, Queen's University Belfast, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.373008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Piessevaux, Hubert. "Pathophysiological role of fundic tension receptors in functional dyspepsia." Université catholique de Louvain, 2004. http://edoc.bib.ucl.ac.be:81/ETD-db/collection/available/BelnUcetd-12232003-221959/.

Full text
Abstract:
This work has tried to provide better insight in some pathophysiological factors involved in functional dyspepsia. We have identified several experimental evidences supporting the hypothesis that activation of transducers of wall tension at the level the proximal stomach might be the key to the genesis of at least some of the symptoms. One of the mechanisms by which this activation may be enhanced in patients is the presence of defective accommodation of the proximal stomach in response to a meal. This abnormality was present in a large subgroup of patients and was associated to the presence of early satiety. Pharmacological modulation of the gastric wall tension resulted in concomitant changes in symptom severity, both in health and in functional dyspepsia patients. Special attention has been given to provide the clinician with better tools to investigate his patient, in the perspective of the prescription of a treatment aimed at restoring a defective mechanism. / Ce travail a tenté d'améliorer la compréhension de certains mécanismes physiopathologiques de la dyspepsie fonctionnelle. Nous avons identifié plusieurs arguments expérimentaux soutenant l'hypothèse disant que c'est l'activation de mécanorécepteurs sensibles à la tension pariétale qui est reponsable d'au moins un des symptômes de l'affection. Un des mécanismes par lesquels cette activation peut accrue chez les patients est la présence d'un défaut de l'accommodation gastrique post-prandiale. Cette anomalie a été retrouvée dans une large proportion des patients et est associée à la présence de satiété précoce. Les modifications du tonus gastrique ont résulté dans de modifications concomitantes des symptômes aussi bien chez les volontaires que chez les patients atteints de dyspepsie fonctionnelle.Une attention particulière a été portée sur le développement de nouveaux outils permettant de caractériser les patients dans la perspective de la prescription d'un traitement visant à corriger un mécanisme défectueux.
APA, Harvard, Vancouver, ISO, and other styles
9

Loffeld, Rudolf Johannes Louis Franciscus. "Dyspepsia and campylobacter associated gastritis clinical and pathological studies /." [Maastricht : Maastricht : Rijksuniversiteit Limburg ; University Library, Maastricht University [Host], 1989. http://arno.unimaas.nl/show.cgi?fid=5556.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Mahadeva, Sanjiv. "Dyspepsia in a multi-racial South East Asian Population." Thesis, University of Leeds, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.511136.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Dyspepsia"

1

Piracha, Kashif. Dyspepsia. Cham: Springer Nature Switzerland, 2023. http://dx.doi.org/10.1007/978-3-031-26914-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Joseph, Talley Nicholas, ed. Dyspepsia. London: Baillière Tindall, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Tominaga, Kazunari, and Hiroaki Kusunoki, eds. Functional Dyspepsia. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-13-1074-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Duvnjak, Marko, ed. Dyspepsia in Clinical Practice. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-1730-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Brendan, Delaney, and National Co-ordinating Centre for HTA (Great Britain), eds. The Management of dyspepsia: A systematic review. Alton: Core Research on behalf of the NCCHTA, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

National Institute for Clinical Excellence., ed. Indigestion (dyspepsia) in adults: Understanding NICE guidance - information for people with dyspepsia, their families and carers, and the public. London: NICE, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Song, F. Functional dyspepsia: A review of scientific and policy issues. York: Centre for Health Economics, University of York, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Fujian, Song. Functional dyspepsia: A review of scientific and policy issues. York: York University, Centre for Health Economics, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Michael, Lancaster-Smith, ed. Ulcer and non-ulcer dyspepsias. Lancaster: MTP Press, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Thompson, W. Grant. The ulcer story: The authoritative guide to ulcers, dyspepsia, and heartburn. New York: Plenum Press, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Dyspepsia"

1

Talley, Nicholas J., Kate Napthali, and Kenneth McQuaid. "Dyspepsia." In Practical Gastroenterology and Hepatology Board Review Toolkit, 70–73. Oxford, UK: John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781119127437.ch11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Everhart, Kelly, and Brian E. Lacy. "Dyspepsia." In Functional and Motility Disorders of the Gastrointestinal Tract, 61–73. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-1498-2_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Poitras, P. "Dyspepsia." In The Digestive System: From Basic Sciences to Clinical Practice, 321–23. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-98381-9_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Dong, Ling, and Rui Zeng. "Dyspepsia." In Handbook of Clinical Diagnostics, 51–52. Singapore: Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-7677-1_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Smith, Peter, and David Colin-Thomé. "Dyspepsia." In Guide to the Primary Care Guidelines, 79–89. 4th ed. London: CRC Press, 2022. http://dx.doi.org/10.1201/9781909368903-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Metze, Dieter, Tam Nguyen, Birgit Haack, Alexander K. C. Leung, Noriko Miyake, Naomichi Matsumoto, A. J. Larner, et al. "Dyspepsia." In Encyclopedia of Molecular Mechanisms of Disease, 557–58. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-29676-8_525.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Oshima, Tadayuki, and Hiroto Miwa. "Definition and Prevalence." In Functional Dyspepsia, 3–14. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-13-1074-4_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Horie, Syunji, Kenjiro Matsumoto, and Kimihito Tashima. "Visceral Hypersensitivity Through Transient Receptor Potential Vanilloid 1 Channels (TRPV1) in Functional Dyspepsia." In Functional Dyspepsia, 117–26. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-13-1074-4_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sakurai, Kouichi, and Hiroko Suda. "Efficacy of Acid Suppression Therapy." In Functional Dyspepsia, 129–38. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-13-1074-4_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Takeuchi, Toshihisa, Satoshi Harada, Kazunari Tominaga, and Kazuhide Higuchi. "Prokinetics." In Functional Dyspepsia, 139–45. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-13-1074-4_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Dyspepsia"

1

Tang, Hai-Ying, Ying-De Wang, Yan-Jun Zhang, and Jing-Hui Xie. "Relationship between gastric dysmotility and severity of dyspeptic symptoms in patients with functional dyspepsia." In 2013 10th IEEE International Conference on Control and Automation (ICCA). IEEE, 2013. http://dx.doi.org/10.1109/icca.2013.6565103.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ahmed, Fiza, and Kalpesh Besherdas. "PTH-005 Dyspepsia in 2017: are we adhering to guidelines?" In British Society of Gastroenterology, Annual General Meeting, 4–7 June 2018, Abstracts. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2018. http://dx.doi.org/10.1136/gutjnl-2018-bsgabstracts.27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Feng, Min. "Analysis of influencing factors on the efficacy of functional dyspepsia." In 2017 5th International Conference on Machinery, Materials and Computing Technology (ICMMCT 2017). Paris, France: Atlantis Press, 2017. http://dx.doi.org/10.2991/icmmct-17.2017.285.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Aboelmagd, M., F. Rageh, and M. Elhamouly. "PATTERN OF ENDOSCOPIC FINDINGS IN PATIENTS WITH UNINVESTIGATED DYSPEPSIA IN EGYPT." In ESGE Days 2018 accepted abstracts. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1637507.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Madisch, A., and P. Funk. "Menthacarin®​ in functional dyspepsia – a systematic review and meta-analysis." In Phytotherapiekongress 2023 – Phytotherapie im 21. Jahrhundert. Georg Thieme Verlag, 2023. http://dx.doi.org/10.1055/s-0043-1769549.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Buckle, Rachel L., Lydia C. Brown, and Imran Aziz. "P273 Randomised trial of traditional dietary advice in postprandial functional dyspepsia." In BSG LIVE’23, 19–22 June, ACC Liverpool. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2023. http://dx.doi.org/10.1136/gutjnl-2023-bsg.341.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Zhussupova, AI, EA Izatullayev, KZ Kamytbekova, AV Maulenova, OV Nikolaeva, and GE Zhussupova. "Effect of herbal syrup “Limonidin” at the functional non ulcer dyspepsia." In GA 2017 – Book of Abstracts. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1608593.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ulrich-Merzenich, G., A. Shcherbakova, S. Rabini, T. A. Thumann, E. M. Pferschy-Wenzig, R. Bauer, and R. M. Ammar. "Elucidation of multi-target mechanisms of STW5-II on functional dyspepsia." In GA – 69th Annual Meeting 2021, Virtual conference. Georg Thieme Verlag, 2021. http://dx.doi.org/10.1055/s-0041-1736882.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hu, Jieqiong. "Clinical and Psychological Features of Overlapping Dyspepsia in Gastroesophageal Reflux Disease." In ISAIMS 2021: 2nd International Symposium on Artificial Intelligence for Medicine Sciences. New York, NY, USA: ACM, 2021. http://dx.doi.org/10.1145/3500931.3500966.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ch, Suraj Kumar, Vikas Reddy V., Ramesh Kumar B., Uma Devi M., and Sahitya Reddy L. "Unexpected Finding on Endoscopy Done for Evaluation of Dyspepsia—GI Melanoma." In ENDOCON 2024. Thieme Medical and Scientific Publishers Pvt. Ltd., 2024. http://dx.doi.org/10.1055/s-0044-1786280.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Dyspepsia"

1

Popa, Stefan Lucian, Dinu Iuliu Dumitrascu, Cristina Pop, Teodora Surdea-Blaga, Abdulrahman Ismaiel, Giuseppe Chiarioni, Dan Lucian Dumitrascu, Vlad Dumitru Brata, and Simona Grad. Exclusion Diets in Functional Dyspepsia. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2022. http://dx.doi.org/10.37766/inplasy2022.5.0026.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Dai, Ning, Qingyun He, Xuehan Liu, Min Xiong, Min Fang, Xun Li, Duoduo Li, Hongliang Liu, and Jianping Liu. Tuina for functional dyspepsia: Protocol for a systematic review and meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, February 2021. http://dx.doi.org/10.37766/inplasy2021.2.0066.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Gao, Hui, Jingyao Zhang, Xi Wang, Xue Han, Yu Liu, Chenxu Liu, and Aiyangzi Lu. Systematic Review and Meta-analysis of Sanren Decoction and Domperidone in the treatment of Functional Dyspepsia. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2021. http://dx.doi.org/10.37766/inplasy2021.9.0084.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Liu, Yuzhou, Yang Zhang, Zhijia Zhang, Qiang Fu, Yin Fu, Zhixiang Li, Chenyu Zhang, and Xiaoyu Wang. Efficacy of Li-Zhong Decoction in the treatment of patients with functional dyspepsia: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0029.

Full text
Abstract:
Review question / Objective: To evaluate the safety and efficacy of LZD in the treatment of FD. In this study, all theory is adopted the soup randomized controlled trials for the treatment of functional dyspepsia. Condition being studied: Although the disease is not life-threatening, it can take a psychological and financial toll on sufferers. At present, the efficacy of conventional treatment is not significant. Previous studies have shown that Lizhong decoction is safe and effective, but there is a lack of systematic evaluation. The purpose of this study was to systematically study the efficacy of LZD in the treatment of FD patients.
APA, Harvard, Vancouver, ISO, and other styles
5

Dai, Ning, Yfei Xu, Ruixue Hu, Xuejiao Wang, Botan Li, and Feng Li. Xiangshaliujun Decoction for functional dyspepsia: A Protocol for systematic review and meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2020. http://dx.doi.org/10.37766/inplasy2020.9.0033.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Wu, Jingjie, Yao Wei, Yu LONG, Yaoxin Chen, and Nierui Huang. Chinese patent medicine for functional dyspepsia effects: a protocol for systematic review and Bayesian network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, October 2021. http://dx.doi.org/10.37766/inplasy2021.10.0057.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lu, Ai Yang Zi, Hui Gao, Lei Hao, Xi Wang, Cheng Shi, and Yixin Zhang. Systematic evaluation and Meta-analysis of Three Seeds Decoction in the treatment of functional dyspepsia compared with cisapride and mosapride. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2021. http://dx.doi.org/10.37766/inplasy2021.6.0084.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

He, Qingyun, and Ning Dai. Melatonin or melatonin receptor agonist for treatment of functional dyspepsia: a systematic review and meta‑analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2024. http://dx.doi.org/10.37766/inplasy2024.4.0078.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wu, Xiaoyan, Weijun Jiang, Chuixia Shi, Hui Qian, Xnguo Fan, and Ping Zhou. The Clinical Efficacy of Acupoint Sticking Combined with Massage to Treatment Functional Dyspepsia: A protocol of systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2020. http://dx.doi.org/10.37766/inplasy2020.11.0072.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

D'Souza, Arun, Katharina Zink, Jost Langhorst, Manfred Wildner, Carolin Stupp, and Thomas Keil. How effective is drinking natural mineral water against heartburn from functional dyspepsia, gastroesophageal reflux disease or other causes? A systematic review of clinical intervention studies. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2024. http://dx.doi.org/10.37766/inplasy2024.1.0007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography